Oura Valued at $11 Billion After $900 Million Funding Round

Oura, the Finnish health and wellness technology company, announced Tuesday a significant Series E funding round, securing over $900 million and catapulting its valuation to $11 billion. This influx of capital positions Oura to further solidify its dominance in the increasingly competitive smart ring market.

The funding round was spearheaded by Fidelity Management & Research Company, with notable participation from new investor ICONIQ and contributions from Whale Rock and Atreides. This diverse investor base underscores the broad appeal of Oura’s vision and the perceived potential of its technology.

“With this investment, we will accelerate innovation, expand our global reach, and set a new standard for what wearables can achieve in advancing preventive health,” stated CEO Tom Hale, signaling the company’s ambitious growth trajectory.

Oura, which recently earned the No. 23 spot on CNBC’s 2025 Disruptor 50 List, has now raised approximately $1.5 billion in total funding, according to company releases. This substantial financial backing provides a significant competitive advantage in a market where R&D and strategic partnerships are crucial for sustained growth.

The company is best known for its Oura Ring, a sleek wearable device that tracks a variety of physiological data, including sleep patterns, activity levels, and heart rate variability. Oura’s primary competitors include other smart ring manufacturers like Samsung and RingConn, as well as established players in the fitness tracker space like Whoop and Garmin. The differentiated factor for Oura is its focus on overall wellness tracking and providing actionable insights based on the collected data.

In September, Oura revealed that it has sold over 5.5 million Oura Rings since its launch in 2015, representing a substantial increase from the 2.5 million rings reported in June 2024. The company also reported revenue exceeding $500 million in 2024, more than double the previous year’s figures, with projections to reach $1 billion in sales this year. These figures indicate strong market adoption and increasing consumer demand for personalized health monitoring solutions.

Oura is actively expanding its feature set to compete with more versatile wearable devices like Apple Watch and Samsung smartwatches. This strategic diversification aims to capture a larger segment of the health and wellness market and cater to a broader range of user needs.

Alongside the introduction of the new Oura Ring 4 Ceramic, the company recently launched Health Panels, a service that allows users to schedule blood tests and view their lab results directly within the Oura App. This integration of diagnostic testing capabilities marks a significant step towards comprehensive health management.

Users can monitor up to 50 biomarkers and receive personalized health insights and recommendations for diet and activity from Oura’s AI-powered Advisor. This data-driven approach to personalized wellness is a key differentiator for Oura, empowering users to make informed decisions about their health.

Furthermore, Oura has partnered with Dexcom, a leading innovator in glucose monitoring technology, to integrate Dexcom glucose data with the biometric data collected by the Oura Ring. This collaboration enables users to track their glucose levels in conjunction with other health metrics, offering a more holistic view of their metabolic health.

“We’re proud to be building not just a product, but a global movement toward proactive health—helping people understand their bodies, make better lifestyle decisions, and connect more effectively with their healthcare providers,” Hale concluded. Oura’s vision extends beyond simply tracking data; it aims to empower individuals to take control of their health and well-being through personalized insights and actionable guidance.